| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 440 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 332 | 2021 |
| Structure of the trypanosome cyanide-insensitive alternative oxidase T Shiba, Y Kido, K Sakamoto, DK Inaoka, C Tsuge, R Tatsumi, ... Proceedings of the National Academy of Sciences 110 (12), 4580-4585, 2013 | 211 | 2013 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| Helicobacter pylori Outer Membrane Protein-Related Pathogenesis Y Matsuo, Y Kido, Y Yamaoka Toxins 9 (3), 101, 2017 | 106 | 2017 |
| A broad distribution of the alternative oxidase in microsporidian parasites BAP Williams, C Elliot, L Burri, Y Kido, K Kita, AL Moore, PJ Keeling PLoS pathogens 6 (2), e1000761, 2010 | 82 | 2010 |
| Anaerobic NADH-Fumarate Reductase System Is Predominant in the Respiratory Chain of Echinococcus multilocularis, Providing a Novel Target for the … J Matsumoto, K Sakamoto, N Shinjyo, Y Kido, N Yamamoto, K Yagi, ... Antimicrobial Agents and Chemotherapy 52 (1), 164-170, 2008 | 81 | 2008 |
| Complete biosynthetic pathways of ascofuranone and ascochlorin in Acremonium egyptiacum Y Araki, T Awakawa, M Matsuzaki, R Cho, Y Matsuda, S Hoshino, ... Proceedings of the National Academy of Sciences 116 (17), 8269-8274, 2019 | 78 | 2019 |
| Direct evidence for cyanide-insensitive quinol oxidase (alternative oxidase) in apicomplexan parasite Cryptosporidium parvum: phylogenetic and therapeutic implications T Suzuki, T Hashimoto, Y Yabu, Y Kido, K Sakamoto, C Nihei, M Hato, ... Biochemical and Biophysical Research Communications 313 (4), 1044-1052, 2004 | 72 | 2004 |
| Purification and kinetic characterization of recombinant alternative oxidase from Trypanosoma brucei brucei Y Kido, K Sakamoto, K Nakamura, M Harada, T Suzuki, Y Yabu, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1797 (4), 443-450, 2010 | 65 | 2010 |
| Pharmacophore identification of ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei H Saimoto, Y Kido, Y Haga, K Sakamoto, K Kita The journal of biochemistry 153 (3), 267-273, 2013 | 57 | 2013 |
| Identification of Helicobacter pylori infection in symptomatic patients in Surabaya, Indonesia, using five diagnostic tests M Miftahussurur, S Shiota, R Suzuki, M Matsuda, T Uchida, Y Kido, ... Epidemiology & Infection 143 (5), 986-996, 2015 | 45 | 2015 |
| Mutational analysis of the Trypanosoma vivax alternative oxidase: the E (X) 6Y motif is conserved in both mitochondrial alternative oxidase and plastid terminal oxidase and is … K Nakamura, K Sakamoto, Y Kido, Y Fujimoto, T Suzuki, M Suzuki, ... Biochemical and biophysical research communications 334 (2), 593-600, 2005 | 44 | 2005 |
| Selective cytotoxicity of dihydroorotate dehydrogenase inhibitors to human cancer cells under hypoxia and nutrient-deprived conditions Y Miyazaki, DK Inaoka, T Shiba, H Saimoto, T Sakura, E Amalia, Y Kido, ... Frontiers in pharmacology 9, 997, 2018 | 40 | 2018 |
| Next-generation sequencing of the whole bacterial genome for tracking molecular insight into the broad-spectrum antimicrobial resistance of Helicobacter pylori clinical … E Tshibangu-Kabamba, PJ Ngoma-Kisoko, VP Tuan, T Matsumoto, ... Microorganisms 8 (6), 887, 2020 | 35 | 2020 |
| Extremely low Helicobacter pylori prevalence in North Sulawesi, Indonesia and identification of a Maori-tribe type strain: a cross sectional study M Miftahussurur, J Tuda, R Suzuki, Y Kido, F Kawamoto, M Matsuda, ... Gut pathogens 6, 1-8, 2014 | 32 | 2014 |
| Three redox states of Trypanosoma brucei alternative oxidase identified by infrared spectroscopy and electrochemistry A Marechal, Y Kido, K Kita, AL Moore, PR Rich Journal of Biological Chemistry 284 (46), 31827-31833, 2009 | 32 | 2009 |
| Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling S Kitajima, T Miki, Y Takegami, Y Kido, M Noda, E Hara, A Shamma, ... Oncogene 30 (6), 737-750, 2011 | 30 | 2011 |
| Neutralizing type I interferon autoantibodies in Japanese patients with severe COVID-19 S Eto, Y Nukui, M Tsumura, Y Nakagama, K Kashimada, Y Mizoguchi, ... Journal of Clinical Immunology 42 (7), 1360-1370, 2022 | 29 | 2022 |
| Prevalence of sARS-CoV-2–specific antibodies, japan, june 2020 T Yoshiyama, Y Saito, K Masuda, Y Nakanishi, Y Kido, K Uchimura, ... Emerging Infectious Diseases 27 (2), 628, 2021 | 29 | 2021 |
Yu NakagamaOsaka Metropolitan University確認したメール アドレス: omu.ac.jp
